Chelsea Hospital appoints new Chief Medical Officer Fazleomar Mahmood

Following an extensive search and review of candidates, Chelsea Hospital has named Fazleomar Mahmood, MD, FACP, FACR, as the hospital’s new chief medical officer (CMO). Since December 2022, Dr. Mahmood has served as the hospital’s interim CMO, where he has continued to advance patient safety and high-quality care.

“Dr. Mahmood is a long-serving member of our medical staff and a well-respected leader at all levels of our organization, from physicians to colleagues to the hospital administration,” said Ben Miles, president of Chelsea Hospital. “I am confident he has the experience and wisdom to help steer our organization in the right direction and advance our healing mission throughout the communities we serve.”

As the hospital’s CMO, Dr. Mahmood will continue to oversee all activities with the medical staff and medical staff office, while also continuing to practice as a rheumatologist with Trinity Health IHA Medical Group Rheumatology.  In addition to his service as interim CMO over the past few months, Dr. Mahmood was already a familiar presence at Chelsea Hospital, having served on the Medical Care Review Committee since 2011, and as the current Director of the Utilization Review Committee and Chief of Medicine Service. Dr. Mahmood is a fellowship-trained rheumatologist and is Board-certified in internal medicine and rheumatology.

Chelsea Hospital is a not-for-profit joint venture hospital, whose partners are Trinity Health Michigan, a Catholic health care system, and Michigan Medicine, the academic medical center of the University of Michigan.